3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hodgkin Disease
1
Fatigue
1
Depression
1
Congenital Abnormalities
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
21
Cyclosporine
14
fludarabine phosphate
13
Whole-Body Irradiation
13
Peripheral Blood Stem Cell Transplantation
13
Filgrastim
10
Rituximab
9
Mycophenolic Acid
9
Antilymphocyte Serum
9
Radiotherapy
7
Methotrexate
7
Busulfan
7
Melphalan
6
Psychiatric Rehabilitation
5
Etoposide
5
Dexamethasone
5
Cytarabine
5
Aprepitant
5
fludarabine
4
Vincristine
4
Ondansetron
4
Methylprednisolone
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Cord Blood Stem Cell Transplantation
4
plerixafor
3
Zidovudine
3
Therapeutics
3
Stem Cell Transplantation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Non-Hodgkin
×
Body Composition
×
Clear all
NCT05188755
2022-12-23
CUPCAKE
University Hospital, Clermont-Ferrand
Phase NA
Completed
44 enrolled